جست‌وجوی استاد و پژوهشگر

Robert Furbankمشاهده پروفایل

استاد

• Plant Phenomics
• C4 Photosynthesis
• Crop Yield Improvement
• +۳ مورد دیگر

Robert Furbank is a Professor and Centre Director at the Australian National University (ANU), leading the ARC Centre of Excellence for Translational Photosynthesis. He specializes in enhancing crop yields through improving photosynthesis and abiotic stress tolerance in cereals like wheat and rice. His work spans plant phenomics, genetic manipulation, and high-throughput phenotyping techniques. He co-leads the C4 Rice Consortium, aiming to introduce C4 photosynthesis into rice to boost productivity. Furbank holds a BSc (Hons) from the University of Wollongong (1979) and a PhD from ANU (1982). He has received prestigious awards, including the Queen Elizabeth II Research Fellowship (1987) and the CSIRO Plant Industry Leadership Award (2014). Research interests include C3/C4 photosynthesis mechanisms, carbon allocation, and developing tools for plant phenomics. He collaborates internationally with organizations like CIMMYT and IRRI, focusing on translational research to bridge experimental findings with crop improvement. His recent projects address heat tolerance in wheat and satellite-based phenotyping for crop analysis. Education: Bachelor of Science (First Class Honours), University of Wollongong, 1979 PhD, Australian National University, 1982 Research Highlights: Combining molecular genetics and phenomics to understand genetic variation in photosynthesis; developing CO2-concentrating mechanisms in rice; improving wheat yield via high-throughput measurement tools. Awards: Queen Elizabeth II Research Fellowship (1987) ACT ICT Innovation Award (2013) CSIRO Plant Industry Leadership Award (2014) Grants and Collaborations: Leads major initiatives like the ARC Centre and participates in global consortia such as the International Wheat Yield Partnership. His work integrates advanced imaging and machine learning for crop trait prediction.

Jennifer Bartonمشاهده پروفایل

استاد

• Biomedical Engineering
• Bioinstrumentation
• Biomedical Optics
• +۵ مورد دیگر

Jennifer Barton is a Professor at the University of Arizona in the College of Engineering, with appointments in Biomedical Engineering, Electrical and Computer Engineering, Optical Sciences, and Biosystems Engineering. She serves as the Interim Director of the BIO5 Institute and has held leadership roles such as Department Head of Biomedical Engineering and Interim Vice President for Research. BS and MS in Electrical Engineering from the University of Texas at Austin and University of California Irvine PhD in Biomedical Engineering from the University of Texas at Austin (1998) Her research in Biomedical Optics focuses on developing miniature endoscopes combining optical coherence tomography and fluorescence spectroscopy for early ovarian and colon cancer detection . She also explores light-tissue interaction and dynamic optical properties of blood , leading to novel laser therapies for skin disorders. Her publications span optical imaging device design , cancer detection , and multimodal endoscopes . Recent works emphasize machine learning integration for diagnostic accuracy and 3D printed optical components . Women of Impact Research Innovation & Impact, University of Arizona (2022) Thomas R. Brown Distinguished Chair, College of Engineering (2020) Best Campus Collaborator, Tech Launch Arizona (2019) President's Award, SPIE (2016) She mentors students in biomedical engineering and leads the Tissue Optics Lab , an interdisciplinary team building novel imaging devices for healthcare innovation.

• T cell immunology
• Immune tolerance
• Checkpoint inhibitor immunotherapy
• +۵ مورد دیگر

Martina Damo serves as Assistant Professor in the Department of Medicine, Section of Rheumatology at the University of Chicago School of Medicine, where she joined the faculty in October 2023. She leads a research laboratory investigating immune checkpoint receptors on T cells and their role in immunological tolerance, with particular focus on how checkpoint blockade immunotherapy causes immune-related adverse events (irAEs) in cancer patients. Her work aims to identify druggable tolerance pathways and develop bioengineered therapies for tolerance modulation. Dr. Damo's educational background includes: PhD in Bioengineering from Swiss Federal Institute of Technology in Lausanne (EPFL), 2016 Postdoctoral Fellowship in Immunobiology at Yale University, 2022 Instructor position at Yale University, 2023 Her research centers on T cell immunology in physiological and pathological contexts, with emphasis on peripheral tissue immunity. She investigates mechanisms of immune tolerance in skin and liver environments, neoantigen recognition by T cells, and the pathogenesis of irAEs following cancer immunotherapy. Her laboratory employs advanced techniques including clonal lineage tracing, mouse models of cancer and autoimmunity, and bioengineering approaches for therapeutic development. Analysis of her publication history (2011-2025) reveals an evolving research trajectory from foundational work in antigen-specific tolerance and gene therapy (2011-2015) to contemporary focus on T cell exhaustion, checkpoint biology, and cancer immunotherapy applications (2018-2025). Her most cited works involve CD8+ T cell dynamics in tumors and viral infections, with consistent emphasis on translational applications. Key thematic areas include T cell tolerance mechanisms, irAE pathogenesis, and bioengineered tolerance-inducing therapeutics. Dr. Damo actively mentors within her research laboratory and collaborates extensively with immunology researchers including Jeffrey Hubbell, Thomas Gajewski, and Melody Swartz. Her work has attracted significant attention with multiple publications exceeding 100 citations, substantial social media engagement (over 250 X posts), and patent references (23 patents citing her work). She maintains active research funding supporting her laboratory's investigations into T cell tolerance pathways. Her laboratory operates within the University of Chicago's immunology research ecosystem, collaborating with colleagues in the Department of Medicine including Maria-Luisa Alegre and James Curran. Current projects focus on developing targeted approaches to prevent irAEs while preserving anti-tumor efficacy of checkpoint inhibitors, leveraging her expertise in tissue-specific immune regulation.

Vivian Liمشاهده پروفایل

استاد پژوهشی

• Stem Cells
• Tumour Biology
• Developmental Biology
• +۶ مورد دیگر

Vivian Li is a Senior Group Leader and Assistant Research Director at The Francis Crick Institute in London, UK, leading a research group focused on intestinal stem cell biology and colorectal cancer mechanisms. Dr. Li earned her PhD from the University of Hong Kong's Department of Pathology in 2008, researching molecular mechanisms of human colonic development and tumorigenesis, for which she received the Gold Medal Prize. She then completed postdoctoral training with Hans Clevers at the Hubrecht Institute in the Netherlands, funded by the Croucher Foundation Fellowship, focusing on Wnt pathway proteomics and intestinal stem cell genes using transgenic mouse models. Her research program investigates how stem cells maintain healthy gut tissue and what goes wrong during cancer development, with particular emphasis on Wnt signaling pathways. Dr. Li's laboratory utilizes advanced organoid technology ('mini-guts') to study stem cell behavior in three-dimensional cultures, gene editing techniques, and state-of-the-art imaging approaches. Her work spans developmental biology, stem cell research, and cancer biology with significant translational implications. Analysis of her recent publications (2022-2025) reveals a strong focus on cancer stemness mechanisms, intestinal regeneration pathways, Wnt signaling components, and innovative organoid modeling approaches for colorectal cancer. Her research consistently bridges basic science with potential clinical applications in gastrointestinal medicine. Gold Medal Prize for PhD thesis Croucher Foundation Fellowship Dr. Li established her independent laboratory at the MRC National Institute for Medical Research in February 2013 and transitioned to the Francis Crick Institute in 2015. Her research aims to develop tumor-specific therapies for bowel cancer and grow replacement human gut tissue for transplantation or drug testing platforms. She leads a multidisciplinary team utilizing cutting-edge techniques including reverse mouse genetics, ex vivo organoid cultures, and advanced genomic and proteomic analyses to investigate stem cell regulation in health and disease. Her laboratory at the Crick Institute operates within the Biological Research Facility and collaborates extensively with other research groups both within the institute and internationally, contributing significantly to understanding intestinal stem cell niche dynamics and cancer development mechanisms.

• Bioelectronics
• Neural Interfaces
• Neuroprosthetics
• +۵ مورد دیگر

Polina O. Anikeeva is a Professor of Materials Science and Engineering and Associate Director of the Research Laboratory of Electronics (RLE) at MIT. She leads the Bioelectronics Group, focusing on developing minimally invasive neural interfaces and neuroprosthetics using advanced materials. Her work integrates materials chemistry, nanotechnology, and microfabrication to enhance biocompatibility and signal quality in neural devices for conditions like Parkinson’s disease and major depressive disorder. Education: Bachelor of Science in Physics, St. Petersburg State Polytechnic University (2003) PhD in Materials Science, MIT (2009) Postdoctoral Fellowship in Bioengineering, Stanford University Her research emphasizes hybrid organic-inorganic materials and optoelectronic systems for neural recording/stimulation. Key innovations include magnetically actuated sensors, wireless neuromodulation, and flexible optoelectronic fibers. Notable achievements include the NIH Director’s Pioneer Award (2021) and collaborations with the Fashion Institute of Technology on smart textiles. Lab Focus: Bioelectronics Group at RLE develops next-generation neural interfaces, with applications in brain-machine interfaces and paralysis treatment. Recent advances include magnetoelectric nanodiscs for transgene-free neuromodulation and remotely controlled chemomagnetic neural circuits.

David M. Smithمشاهده پروفایل

استاد

• Proteasome Function
• Cancer Biology
• Neurodegenerative Diseases
• +۳ مورد دیگر

David M. Smith is a Professor at the West Virginia University School of Medicine , holding dual appointments in the Biochemistry and Molecular Medicine and Neuroscience departments. He is also a member of the WVU Cancer Institute and affiliated with the Rockefeller Neuroscience Institute . PhD from the University of South Florida School of Medicine Postdoctoral training at Harvard Medical School Research Focus : Molecular mechanisms of proteasome function, including substrate recognition, unfolding, and degradation. His work bridges fundamental enzymology with translational applications in cancer therapy and neurodegenerative diseases like Alzheimer's and Parkinson's. Key Article Trends : Recent publications emphasize proteasome activation mechanisms , neurodegenerative disease models , and structural insights into ATPase function . Grants : NIH R01 GM107129 (Mechanisms regulating proteasomal degradation), NIH R01 AG064188 (Proteasome function in Alzheimer's), and collaborations on projects like Protein-unfolding chaperones for blindness treatment . Lab Personnel : Includes graduate students Thomas Bradley, David Salcedo-Tacuma, Giovanni Howells, and Md Qamrul Islam, along with research technicians and undergraduates. Training emphasizes biochemical, biophysical, and computational techniques.

Marta Zlaticمشاهده پروفایل

پژوهشگر

• Systems neuroscience
• Circuit mechanisms of behaviour
• Learning and memory
• +۲ مورد دیگر

Dr. Marta Zlatic is a Principal Research Associate at the Department of Zoology , part of the School of Biological Sciences at the University of Cambridge. She leads the Zlatic Lab, focusing on the structural and functional relationships within neural circuits. Her research explores how nervous systems integrate sensory information and prior experiences to enable decision-making, emphasizing learning and memory , sensorimotor transformations , and connectomics . Using Drosophila melanogaster larvae as a model organism, her work combines optogenetics , electron microscopy , and functional imaging to decode circuit principles. Recent publications highlight trends in connectome analysis and behavioural neuroscience , with subfields spanning synaptic architecture , neural network modeling , and genetic manipulation techniques . She collaborates with interdisciplinary teams and maintains active research partnerships at the MRC Laboratory of Molecular Biology. Group members include Bernd Breuer, Nicolo Ceffa, Michael Clayton, and other researchers advancing understanding of Drosophila neurobiology. The lab contributes to Cambridge's Athena Swan Bronze Award initiatives for equality and inclusion in research environments.

• Non-coding RNA
• Gene Expression
• Developmental Biology
• +۶ مورد دیگر

Matthew Ronshaugen is a Senior Lecturer in the Division of Developmental Biology & Medicine (L5) at the Faculty of Life Sciences, University of Manchester. He has held academic positions since 2007 as a Manchester Fellow, followed by Lecturer (2012-2017), and Senior Lecturer since 2017. 1991-1995: Bachelor of Arts in Philosophy and Linguistics, University of Nevada, Las Vegas 1995-1997: Master of Science in Systematics, University of Nevada, Las Vegas 1997-2002: Doctor of Philosophy in Cell and Molecular Biology, University of California, San Diego 2003-2007: Ruth L. Kirschstein NIH Postdoctoral Fellow at University of California, Berkeley His research focuses on non-coding RNAs (ncRNAs), particularly their roles in gene expression and developmental differentiation. His lab investigates how ncRNA evolution contributes to metazoan body plan diversification, centering on the Hox complex—a conserved genomic region rich in ncRNAs. He uses tiling microarrays and fluorescent in situ hybridization to analyze ncRNA dynamics in Drosophila, Tribolium, and Parhyale. Recent publications highlight his work on miRNA functions in embryonic development, aging-related changes in myeloid cells, and comparative transcriptomics across arthropods. His team employs genetics tools to dissect ncRNA roles in transcriptional regulation, epigenetic control, and silencing mechanisms. Scientific Awards: Ruth L. Kirschstein NIH Postdoctoral Fellow Manchester Fellow He supervises research on developmental transcriptomes and contributes to datasets on piRNA expression and Hox complex analysis. Collaborations span immunology, genomics, and evolutionary development, with outputs cited in fields like RNA interference, transgenics, and wound healing.

Richard W. Grossمشاهده پروفایل

استاد

• Analytical Chemistry
• Biological Membranes
• Lipidomics
• +۴ مورد دیگر

Dr. Richard W. Gross is Professor of Medicine and Developmental Biology at Washington University School of Medicine and Professor of Chemistry. He holds a PhD from Washington University, MD from New York University Medical School, and BA from Columbia College. His research focuses on the chemical biology of membranes in health and disease, specializing in lipidomics, metabolomics, and membrane signaling. He pioneered shotgun lipidomics technology for direct identification and quantification of lipid molecular species in biological systems. Developed novel shotgun lipidomics technology combining intrasource separation, multidimensional MS, and array analysis Investigates phospholipase regulation and membrane signaling complexes Studies altered lipid metabolism in obesity, diabetes and cardiovascular disease

Gary K. Owensمشاهده پروفایل

استاد

• Cardiovascular Biology
• Atherosclerosis
• Smooth Muscle Cell Biology
• +۴ مورد دیگر

Dr. Gary K. Owens is a Professor in the Department of Molecular Physiology and Biological Physics at the University of Virginia , with a secondary appointment in the Department of Medicine, Division of Cardiology. He serves as Director of the Robert M. Berne Cardiovascular Research Center and leads groundbreaking research on vascular smooth muscle cell (SMC) dynamics in atherosclerosis. His work challenges conventional paradigms about SMC roles in plaque stability and thromboembolic events. Primary Affiliation: University of Virginia Key Titles: Robert M. Beirne Professor of Cardiovascular Research, Professor, Director of CVRC Research Themes include: Cardiovascular Biology Atherosclerosis Pathogenesis Smooth Muscle Cell Plasticity Epigenetic Regulation Inflammatory Signaling Tumor Metastasis Mechanisms Publication Trends (2015–2024) reveal expertise in Nature Medicine and Circulation studies, focusing on SMC gene regulation (Klf4/Oct4), plaque stability, and cross-talk between vascular cells and tumors. His work demonstrates that SMCs account for >80% of advanced lesion cells and that Klf4 inhibition reduces metastasis by >70%. Lab Leadership includes mentoring PhD students Anita Salamon and Victoria Milosek , alongside senior scientists and postdocs. Collaborations span with Dr. Gwen Randolph (Washington University) and Dr. Rosey Kaplan (NIH) on IL1β signaling and metastasis.

Holger Knautمشاهده پروفایل

دانشیار

• Collective Cell Migration
• Actin Polymerization
• RhoA Signaling
• +۴ مورد دیگر

Holger Knaut is an Associate Professor in the Department of Cell Biology at NYU Grossman School of Medicine . His research focuses on understanding the molecular and mechanical mechanisms underlying collective cell migration, tissue morphogenesis, and cytoskeletal dynamics using zebrafish models and quantitative imaging techniques. Key research areas: Collective cell migration, RhoA signaling, focal adhesions, actin polymerization Methodologies: Genetics, live-cell imaging, biomechanical analysis Notable findings: Discovery of rear traction forces in tissue migration, integration of adhesion codes in pattern formation His publications in top journals like Nature Cell Biology and Science demonstrate his expertise in developmental biophysics and cell signaling regulation. Contact: Holger.Knaut@nyulangone.org

• Zebrafish Research
• Vascular Biology
• Lymphatic Development
• +۳ مورد دیگر

Dr. Kazuhide Shaun Okuda is a Senior Lecturer and Group Leader at the La Trobe Institute for Molecular Science, Department of Biochemistry and Chemistry at La Trobe University, Australia. He also holds honorary positions at Peter MacCallum Cancer Centre and the University of Melbourne. With extensive experience in zebrafish research and vascular biology, Dr. Okuda has established himself as an expert in lymphatic development, disease modeling, and drug discovery. Dr. Okuda earned his PhD in Molecular Medicine from the University of Auckland, New Zealand (2010-2014), where he generated groundbreaking zebrafish transgenic lines for lymphatic vessel imaging. His subsequent postdoctoral work at Cancer Research Malaysia and the University of Queensland/Peter MacCallum Cancer Centre focused on anti-cancer therapeutics screening and dynamic signaling events during development and regeneration. His research focuses on understanding lymphoedema mechanisms, identifying therapies that modulate vascular growth, and elucidating dynamic mechanisms of vascular development and disease progression. Dr. Okuda's work has significant potential impact in developing new treatments for lymphoedema and diseases with excessive vascular growth such as cancer and lymphatic malformations. Analysis of Dr. Okuda's publication record shows a consistent focus on vascular and lymphatic development using zebrafish models. His most recent work (2023-2025) demonstrates an expansion into drug delivery systems, advanced imaging techniques, and single-cell analysis approaches while maintaining his core interest in lymphangiogenesis mechanisms and therapeutic interventions. Dr. Okuda has received significant research funding, including a National Health and Medical Research Council Ideas Grant (2024-2027) for his project on 'Cellular signalling and growth control in vascular development and lymphatic malformations.' Primary supervisor of PhD students (X4), La Trobe University (2023-present) Co-supervisor of PhD students (X3), University of Melbourne (2020-present) Co-supervisor of a PhD student, La Trobe University (2023-present) Senior Lecturer and Group Leader, La Trobe Institute for Molecular Science (2023-present) Honorary Scientist, Peter MacCallum Cancer Centre (2023-present) Honorary Fellow, University of Melbourne (2020-present) Dr. Okuda leads a research group at the La Trobe Institute for Molecular Science focused on identifying therapeutic leads/targets that modulate the vasculature and studying dynamic signaling mechanisms in endothelial cells using zebrafish models. His team has made significant contributions to understanding lymphatic development, including the identification of Ddx21 and ribosome biogenesis as novel regulators of embryonic lymphangiogenesis.

• Neurodegenerative Diseases
• Alzheimer's Disease
• Tau Protein Biology
• +۳ مورد دیگر

Dr. Charles Harrington is a Senior Research Fellow at the University of Aberdeen's School of Medicine, Medical Sciences and Nutrition. With a background in microbiology, he has transitioned to become a leading researcher in neurodegenerative diseases, particularly focusing on Alzheimer's disease and tau protein biology. His career spans over four decades, with significant contributions to understanding the molecular mechanisms of protein aggregation in neurodegenerative conditions. BSc (Hons) Microbiology, University of Glasgow (1977) PhD Microbiology, University of Glasgow (1980) Harrington's research interests center on the biology of tau protein in aging and Alzheimer's disease, with emphasis on diseases characterized by protein aggregation and methods to prevent these processes. His work has evolved from early studies on microbial cell walls to current investigations of tau pathology, demonstrating remarkable interdisciplinary expertise. He has developed assays for screening tau aggregation inhibitors and has extensively studied the therapeutic potential of hydromethylthionine. Analysis of his recent publications (2021-2025) reveals a strong focus on tau protein aggregation mechanisms, neuroinflammation, synaptic dysfunction in neurodegenerative diseases, and the therapeutic effects of tau aggregation inhibitors. His work frequently examines interactions between different therapeutic approaches, particularly how cholinesterase inhibitors might interfere with tau-targeting treatments. Harrington's research bridges molecular mechanisms with clinical applications, contributing significantly to the development of biomarkers and therapeutic strategies for Alzheimer's disease and related tauopathies. As Chief Scientific Officer for TauRx Therapeutics Ltd, Harrington oversees non-clinical activities for a company conducting phase 3 trials of hydromethylthionine. His collaborative work spans multiple international institutions, with numerous co-authors across neuroscience, biochemistry, and clinical research fields. While specific grant information isn't detailed in the provided text, his extensive publication record suggests substantial research funding support over his career. Harrington's laboratory work appears focused on tau transgenic mouse models, particularly investigating how tau pathology affects synaptic function, neurotransmitter systems, and behavioral outcomes. His research team has developed sophisticated methods for studying protein aggregation and its consequences in neurodegenerative disease models.

Reilly T. Enosمشاهده پروفایل

استادیار

• Obesity
• Metabolic Disease
• Sex Differences in Metabolism
• +۹ مورد دیگر

Reilly T. Enos, PhD, is an Assistant Professor in the Department of Pathology, Microbiology & Immunology at the University of South Carolina School of Medicine. His research focuses on the molecular mechanisms of sex differences in obesity, particularly metabolic and inflammatory processes influenced by sex steroids. The Enos Lab employs rodent models and advanced metabolic phenotyping to investigate menopause-related metabolic dysfunction and complementary therapies. PhD, Exercise Science (Applied Physiology), University of South Carolina, 2013 Post-Doctoral, Complementary and Alternative Medicine in Cancer and Obesity, University of South Carolina School of Medicine, 2017 MS, Exercise Physiology, Baylor University, 2009 BS, Dietetics, University of Northern Colorado, 2010 BA, Spanish & Physical Education, College of Wooster, 2007 Dr. Enos’s research spans immunometabolism, obesity, cancer cachexia, and gut microbiota. His work explores how dietary components (e.g., quercetin, emodin), hormonal status (especially estrogen), and immune modulation (e.g., miR-155, macrophages) influence metabolic and oncological outcomes. He investigates sex-specific responses to high-fat diets, inflammation, and therapeutic interventions using transgenic and diet-induced mouse models. His recent publications highlight trends in metabolic physiology, inflammation, and cancer, often examining the interplay between adipose tissue, immune cells, and hormonal regulation. Key themes include the impact of vivarium conditions on reproducibility, the role of microRNAs in tumorigenesis, and the safety and efficacy of natural compounds. Dr. Enos has not been awarded any listed scientific prizes or fellowships in the provided texts. He advises a research team focused on metabolic and inflammatory disease models, frequently collaborating with researchers such as Erin A. Murphy and Kandy T. Velázquez. His lab receives funding for studies on obesity, cancer, and complementary medicine, though specific grants are not detailed. The lab is equipped for metabolic phenotyping and rodent model studies. The Enos Lab is dedicated to understanding sex-specific metabolic regulation and developing targeted therapies for obesity and cancer-related metabolic disorders, with a focus on translational relevance and experimental rigor.

Jochen Hermsمشاهده پروفایل

استاد

• Biomedical Neuroscience
• Cellular & Systems Neuroscience
• Behavioral & Cognitive Neuroscience
• +۵ مورد دیگر

Prof. Dr. Jochen Herms serves as Director at the LMU Center for Neuropathology and Prion Research , while maintaining a dual affiliation with the German Center for Neurodegenerative Diseases (DZNE) Munich as Head of Translational Brain Research. His work bridges clinical and experimental neuropathology, focusing on synaptic degeneration in neurodegenerative conditions. Ludwig-Maximilians-Universität München (LMU): Director, Experimental Neuropathology DZNE Munich: Translational Brain Research Research Themes: Primary: Biomedical Neuroscience Secondary: Cellular & Systems Neuroscience Tertiary: Behavioral & Cognitive Neuroscience Key investigations include: Physiological roles of neurodegenerative disease proteins (APP, presenilins, BACE, tau, α-synuclein) In vivo two-photon imaging of transgenic Alzheimer's models Neuronal calcium homeostasis in neurodegeneration High-throughput drug screening for AD/PD Active research collaborations leverage funding from: German Research Foundation (DFG) - Munich Cluster for Systems Neurology (EXC 2145 SyNergy) BMBF, BMWi, EU consortia Bavarian Research Foundation Wilhelm Sander Foundation